Cell-El presents their research and projects at international conferences
Can Serum Protein Biomarkers Identify Children at High Risk for Autism Spectrum Disorder?
Presented by Fred Samuels, CEO, Cell-El at the Synchrony Symposium, October, 2023
Autism Spectrum Disorders and Stem Cell Therapies: A Promising New Direction
Team: Benjamin Gesundheit, Ronald Ellis, Philip D. Zisman, Nadya Lisovoder, Lea Hochbaum et al.
Description: Cell-El presents projects on the innovative diagnosis and treatment of Autism Spectrum Disorder (ASD). Read more